Hepatitis C virus in prisoners

R. De Mercato, J. P. Cantiello, U. Celentano, U. Giani, A. Romano, D. Guarnaccia, A. D'Antonio

Research output: Contribution to journalArticlepeer-review


The purpose of this study was to assess the epidemiology of hepatitis C virus (HCV) in prisoners and outpatients attending our center. 2205 specimens were consecutively obtained under code and screened for anti-HCV by the second generation RIBA test and Hepatitis B core antibody (HBcAb) by CORAB test. After serum samples were tested, we reviewed demographic data and categorized four groups: Intravenous drug abusers (IVDAs), prisoners and apparently healthy subjects and warders. Anti-HCV prevalence was 59.4% in 613 IVDAs, 15.5% in 756 prisoners, 2.6% in 454 healthy subjects and 2.8% in 145 warders. These findings suggest that prisoners may be considered a group at increased risk for HCV infection.

Original languageEnglish
Pages (from-to)89-91
Number of pages3
JournalMinerva Medica
Issue number3
Publication statusPublished - 1995


  • hepatitis C virus
  • prisoners

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Hepatitis C virus in prisoners'. Together they form a unique fingerprint.

Cite this